薛定锷之猫2020-08-11 09:17
$Rubius Therapeutics(RUBY)$ Flagship VC主控38m, Capital World和Research各占1.8+1.5m, BG 4.3m, ARCH 2.6m查看全文
chuminhua2020-03-16 15:37
3/12,Rubius Therapeutics$Rubius Therapeutics(RUBY)$ 在2019年报中披露,主要在研药物RTX-134治疗苯丙酮尿症(PKU)的Ib期研究数据“无法解释”,因此停止了临床研究,并将公司资源集中在肿瘤和自身免疫疾病药物上。查看全文
美股滚雪球2020-02-18 16:42
老朋友是否给出新机会,查看内容更新$Rubius Therapeutics(RUBY)$ $Scynexis(SCYX)$ $Millendo疗法(MLND)$查看全文
牛唐2018-07-28 22:32
$Rubius Therapeutics(RUBY)$ 是在Flagship VentureLabs孵化的突破性治疗平台,研发管线是建立在其独创的红细胞治疗技术Red-Cell Therapeutics(RCTs)。
RCT技术可将供体的造血干细胞改造成特殊的"治疗性"红细胞,并在体外大规模培养,像"输血"一样将药物回输到患者体内,整...查看全文
$Rubius Therapeutics(RUBY)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-030329 Act: 34 Size: 2 MB 网页链接
$Rubius Therapeutics(RUBY)$ 8-K Current report, items 3.01 and 5.02 Accession Number: 0001104659-23-028428 Act: 34 Size: 204 KB 网页链接
$Rubius Therapeutics(RUBY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001088875-23-000072 Act: 34 Size: 10 KB 网页链接
$Rubius Therapeutics(RUBY)$ PRER14A Preliminary Proxy Soliciting materials Accession Number: 0001104659-23-027696 Act: 34 Size: 2 MB 网页链接
$Rubius Therapeutics(RUBY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-026139 Size: 5 KB 网页链接
$Rubius Therapeutics(RUBY)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-025672 Act: 34 Size: 508 KB 网页链接
$Rubius Therapeutics(RUBY)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001709401-23-000005 Act: 34 Size: 7 MB 网页链接
$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025604 Act: 33 Size: 28 KB 网页链接
$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025605 Act: 33 Size: 28 KB 网页链接
$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025606 Act: 33 Size: 28 KB 网页链接